Growth Metrics

Ocugen (OCGN) EBITDA Margin (2014 - 2026)

Ocugen posted quarterly EBITDA Margin of 1257.66% for Q1 2026, down 22066.0% year-on-year from N/an in Q1 2025, and down 113.71% on a QoQ basis from 9172.54% in Q4 2025.

Ocugen (OCGN) has 7 years of EBITDA Margin data on file, last reported at 1257.66% in Q1 2026.

  • For the quarter ending Q1 2026, EBITDA Margin fell 22066.0% year-over-year to 1257.66%; the trailing twelve-month figure through Mar 2026 stood at 1607.05% (down 33627.0% YoY), and the FY2025 full-year result was 1537.12%, down 20479.0% from the prior year.
  • EBITDA Margin for Q1 2026 stood at 1257.66%, down from 9172.54% in the prior quarter.
  • Across five years, EBITDA Margin topped out at 9172.54% in Q4 2025 and bottomed at 5127.25% in Q3 2022.
  • The 5-year median for EBITDA Margin is 1257.66% (2026), against an average of 1493.56%.
  • The widest annual swing landed in 2023, when EBITDA Margin sank 141694 bps; it then soared 1098602 bps in 2025.
  • A 5-year view of EBITDA Margin shows it stood at 2548.12% in 2022, then soared by 69 bps to 779.06% in 2023, then slumped by 133 bps to 1813.48% in 2024, then surged by 606 bps to 9172.54% in 2025, then tumbled by 114 bps to 1257.66% in 2026.
  • The last three EBITDA Margin figures came in at 1257.66% (Q1 2026), 9172.54% (Q4 2025), and 1141.84% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn -6.43%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 38.10%
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 18.35%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 17.24%
10 Ocugen 452.01 Mn 452.01 Mn - -1,257.66%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -1,257.66%
Dec 31, 2025 9,172.54%
Sep 30, 2025 -1,141.84%
Jun 30, 2025 -1,075.53%
Mar 31, 2025 -1,037.00%
Dec 31, 2024 -1,813.48%
Sep 30, 2024 -1,142.17%
Jun 30, 2024 -1,338.91%
Mar 31, 2024 -1,175.44%
Dec 31, 2023 -779.06%
Sep 30, 2023 -316.63%
Jun 30, 2023 -4,756.29%
Mar 31, 2023 -3,911.29%
Dec 31, 2022 -2,548.12%
Sep 30, 2022 -5,127.25%
Jun 30, 2022 -3,339.35%
Mar 31, 2022 -3,803.00%
Jun 30, 2020 -8,404.65%
Sep 30, 2014 -2.30%